Sarah Stanley
University of California, Berkeley
H-index: 33
North America-United States
Top articles of Sarah Stanley
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Mycobacterial formation of intracellular lipid inclusions is a dynamic process associated with rapid replication | bioRxiv | Daniel M Fines Denise Schichnes Matt Knight Andrea Anaya-Sanchez Nguyen Thuy Thuong Thuong | 2023 |
Disruption of Aldehyde Dehydrogenase 2 protects against bacterial infection | bioRxiv | Samuel B Berry Scott Espich Nguyen TT Thuong Xuling Chang Rajkumar Dorajoo | 2023/8/24 |
Tuberculosis susceptibility in genetically diverse mice reveals functional diversity of neutrophils | bioRxiv | Marietta M Ravesloot-Chavez Erik Van Dis Douglas Fox Xammy H Nguyenla Sagar L Rawal | 2023 |
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens | PLoS pathogens | Huntly M Morrison Julia Craft Rafael Rivera-Lugo Jeffery R Johnson Guillaume R Golovkine | 2023/6/23 |
MarR-Dependent Transcriptional Regulation of mmpSL5 Induces Ethionamide Resistance in Mycobacterium abscessus | Antimicrobial Agents and Chemotherapy | Ronald Rodriguez Nick Campbell-Kruger Jesus Gonzalez Camba John Berude Rachel Fetterman | 2023/4/18 |
Confusion | GIM International: the worldwide magazine for geomatics | MJPM Lemmens | 2015 |
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells | Scientific reports | Xammy Nguyenla* Eddie Wehri* Erik Van Dis* Scott B Biering* Livia H Yamashiro* | 2022/11/2 |
Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection | Journal of Immunology | Robyn M Jong* Erik Van Dis* SB Berry Xammy Nguyenla Alexander Baltodano | 2022/1/15 |
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro | Nature communications | Leiping Zeng Yanxia Liu Xammy Huu Nguyenla Timothy R Abbott Mengting Han | 2022/5/19 |
An intranasal ASO therapeutic targeting SARS-CoV-2 | Nature communications | Chi Zhu Justin Y Lee Jia Z Woo Lei Xu Xammy Nguyenla | 2022/8/3 |
The aldehyde hypothesis: metabolic intermediates as antimicrobial effectors | K Heran Darwin Sarah A Stanley | 2022/4/13 | |
Rapid detection of SARS-CoV-2 RNA in saliva via Cas13 | Nature biomedical engineering | Sita S Chandrasekaran Shreeya Agrawal Alison Fanton Aditya R Jangid Bérénice Charrez | 2022/8 |
Workshop-based learning and networking: a scalable model for research capacity strengthening in low-and middle-income countries | Global health action | Celine Perier Emmanuel Nasinghe Isabelle Charles Leoson Junior Ssetaba Vida Ahyong | 2022/12/31 |
SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA | Biophysical Journal | Amanda Jack Luke Ferro Michael J Trnka Eddie Wehri Amrut Nadgir | 2022/2/11 |
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection | Nature genetics | Scott B Biering Sylvia A Sarnik Eleanor Wang James R Zengel Sarah R Leist | 2022/8 |
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling | Nature communications | Scott B Biering Francielle Tramontini Gomes de Sousa Laurentia V Tjang Felix Pahmeier Chi Zhu | 2022/12/9 |
The B. 1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B. 1 (614G) in Syrian hamsters | PLoS pathogens | Timothy Carroll Douglas Fox Neeltje van Doremalen Erin Ball Mary Kate Morris | 2022/2/10 |
IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α | PLOS Pathogens | Erik Van Dis Douglas M Fox Huntly M Morrison Daniel M Fines Janet Peace Babirye | 2022/7/25 |
SARS-CoV-2 down-regulates ACE2 through lysosomal degradation | Molecular Biology of the Cell | Yi Lu Qingwei Zhu Douglas M Fox Carol Gao Sarah A Stanley | 2022/12/1 |
Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis | 2022/1/18 |
